Meseline Mulokozi

SADC Youth Parliamentarian🇹🇿| Chevening scholar 2025/26 | HER Voice fund Ambassador🇹🇿

[Meseline Mulokozi @meselineraphael]

At the beginning of this week, I attended the Chevening farewell event.

It feels like yesterday when I embarked on this journey, suddenly I am almost at the finish line.

Thank you chevening Scholarships for this once in a lifetime opportunity that gave me friends, colleagues and future partners in the field of public health and beyond.

I have positively grown in so many ways over the last few months and I can’t wait to use the skills.

#Iamchevening

[Meseline Mulokozi @meselineraphael]

I cant wait to meet the next envoy.

All the best to all young people who will be applying for this honourable position.

[African Union @_AfricanUnion]

A New Chapter Begins
Africa's next Youth Envoy could be among the millions of young leaders, innovators, entrepreneurs, activists, and changemakers shaping communities across the continent and the diaspora today.

The African Union will soon launch the call for applications for the next AU Youth Envoy.But before the next chapter begins, we want to hear from you.

1. What issues should the Office champion on behalf of Africa's youth?
https://t.co/UXkknjHqws can the Office better serve young people across the continent and the diaspora?

Your ideas, experiences, and aspirations matter, share your thoughts in the comments using #AUYouthEnvoy

Stay informed. Stay engaged. Stay ready.
Stay tuned.

[Meseline Mulokozi @meselineraphael]

In 2025, the World Health Organization (WHO) recommended the twice-yearly injectable pre-exposure prophylaxis, #Lenacapavir, for #HIV prevention.

This new innovation expands HIV prevention #choices, particularly for people facing challenges with daily adherence and those residing in stigma-dominated communities where accessing HIV services freely can be difficult.

By January 2026, Lenacapavir had been approved by several national regulatory authorities across eastern and southern Africa, including Mozambique. Namibia, Kenya, Uganda, Botswana, Rwanda, Tanzania, Malawi, Zimbabwe, Zambia and South Africa.

However, #efficacy and regulatory approval do not always translate into effective #uptake.

Taking Tanzania as a case study. Condoms are highly effective and widely available, yet according to the Tanzania Demographic Health Survey, some age and gender groups still do not consistently utilise them.

This history changes our critical question from

“Does lenacapivir work?”

To

Are communities willing to use lenacapavir?